A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer
Shee Kwan Phung(University of Minnesota), Martin Felices(University of Minnesota), Quinlan M. Kile(University of Minnesota), S.H. Miller(University of Minnesota System), Nicholas A. Zorko(University of Minnesota Medical Center), Emmanuel S. Antonarakis(University of Minnesota), Trygve D. Nelson(University of Minnesota System), Carly Selleck(University of Minnesota), Jeffrey S. Miller(Science Museum of Minnesota), Yvette Soignier(University of Minnesota System), Mihir Shetty(University of Minnesota), Peter Hinderlie(University of Minnesota), Asha J. Bozicevich(University of Minnesota System), Scott M. Dehm(University of Minnesota), Philippa R Kennedy(University of Minnesota), Melissa Khaw(University of Minnesota), Michael Ehrhardt(University of Minnesota), Laura E. Bendzick(University of Minnesota), Laura E. Kotz(University of Minnesota), Rhett L. Waller(University of Minnesota System), Xianghua Luo(Apple (Israel)), Madison Shackelford(University of Minnesota System), Joshua T. Walker(University of Minnesota System)
Cited by 9
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
|International Journal of Radiation Oncology*Biology*Physics|2009|984